|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() ![]() ![]() ![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pall eBDS:
User Benefits
A Complete Turnkey System
Unsurpassed Sensitivity and Specificity
Single Point Detection Provides Test of Record Prior to Transfusion
Easy to Use with Minimal Platelet Loss
Top Performance Summary for the Pall eBDS: Simple, Sensitive, Seamless
The ten organisms that were selected for determining the performance characteristics of the Pall eBDS were the same genus and species as those responsible for over 98% of all fatalities associated with the transfusion of bacteria contaminated platelets.1 The organisms were tested in platelet products prepared from whole blood derived platelet-rich plasma and apheresis. Samples were collected using the Pall eBDS Sample Set immediately after inoculation (Table 1), and after a 24 hour incubation following inoculation (Table 2). Platelet products were inoculated with test organisms at levels indicated prior to using the Pall eBDS Sample Set. Sample collection into the pouch was followed by 24-hour incubation at 35 °C and thereafter tested.
Sensitive* Table 2 illustrates that 100% of all samples tested positive when sampling occurred after a 24-hour incubation at room temperature. Specific 1. Lee JH. In: Bacterial Contamination of Platelets Workshop, Bethesda, September 24, 1999. (Cited May 3, 2000.) Available from * Sensitivity varies depending on the bioburden and duration of incubation prior to sampling. Table 1. Performance Summary with Sampling Taken at the Time of Inoculation
Table 2. Performance Summary with Sampling Taken 24 Hours After Inoculation
Top The Testing Principle and System Components
Percent Oxygen in Air, the Practical Approach
Pall eBDS Sample Set Incubator and Agitator
Pall eBDS Oxygen Analyzer
A software package that captures the output from the Pall eBDS Oxygen Analyzer and allows the information to be queried into a user-defined report. Top Detect Bacteria in Platelets with Confidence: Steps to Using Pall eBDS
Top Training and Implementation
Customers who use Pall blood products can access up-to-date training and implementation support for compliance with appropriate regulatory guidelines. For details, go to our Customer Care Center. Top Complementary Products
Using a platform of complementary products, blood collection facilities are able to produce a therapeutic dose of platelets that are pooled, leukoreduced, ABO matched, and bacteria tested with culture based detection methods – in other words, an Acrodose Platelet. Read more about:
For the full story, go to A New Platform for Platelet Transfusion Safety. Top |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||